In welcome good news, Telix says the first stage of its pivotal prostate cancer therapeutic trial has hit its desired safety ...

This stock is making its shareholders smile on Tuesday. Let's find out why. The post Why is this ASX 200 share charging 7% higher today? appeared first on The Motley Fool Australia.

Former ET co-host John Tesh revealed he that he far exceeded the wildest expectations of doctors who diagnosed him with cancer more than a decade ago - but he still lives with the disease.

Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on ...

Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, ...

Cancer death rates in the UK have fallen to a historic new low, Cancer Research UK has announced. The charity, which analysed ...

Around 247 in every 100,000 people are thought to die from cancer in any given year, which is a 29 per cent drop on the peak ...

Blood tests are the most common way for health professionals to detect and diagnose a range of medical conditions. But can it ...

Monte Rosa Therapeutics recently reported updated Phase 1/2 data showing that its investigational GSPT1 degrader MRT-2359, in combination with enzalutamide, was well-tolerated and produced positive ...

Men are almost 60 per cent more likely than women to die before the age of 75, according to government figures. One doctor ...

Researchers found men who ejaculated more often had fewer prostate cancer diagnoses, pointing to a possible biological ...

Pub bells will ring out early this evening at 6pm – and each night over the next six days – as part of a new campaign by ...